Anxiety disorders (generalised anxiety): who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• G6PD 0
• NLRP3 1

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Low-Intensity Focused Ultrasound and the Complex Patient

  NCT06297200· Virginia Polytechnic Institute and State University· Updated 9 Nov 2026

  “Unable to recruit any eligible participants.”Registry text, quoted unchanged. Source

• Suspended

  An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

  NCT07329673· Qbtech AB· Updated 25 Sept 2026

  “Enrollment/study activities have been temporarily suspended while the sponsor evaluates internal study priorities and resource allocation. The suspension is not related to participant safety, protocol compliance, data quality, or regulatory concerns.”Registry text, quoted unchanged. Source

• Suspended

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

  NCT04031469· ProgenaBiome· Updated 21 Sept 2026

  “Administrative”Registry text, quoted unchanged. Source

• Withdrawn

  Therapeutic Writing for Adults Suffering From Chronic Pain and Comorbid Mental Health Disorders

  NCT07058532· Toni Salikka· Updated 2 Sept 2026

  “The collaborator could not proceed with the study due to personnel changes.”Registry text, quoted unchanged. Source

• Terminated

  SKY Breath Intervention

  NCT05388110· University of California, San Francisco· Updated 11 Aug 2026

  “The study was terminated due to limited resources and the loss of key study personnel, which made completion of the planned enrollment infeasible. The decision was not based on safety or efficacy concerns.”Registry text, quoted unchanged. Source

• Withdrawn

  Common Factors Group Psychotherapy for General Mental Health Concerns

  NCT06614842· University of Alabama at Birmingham· Updated 18 Jun 2026

  “Inability for consistent recruitment.”Registry text, quoted unchanged. Source

• Terminated

  Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS

  NCT04015596· Massachusetts General Hospital· Updated 20 May 2026

  “Low recruitment”Registry text, quoted unchanged. Source

• Terminated

  Reducing Suicide Risk in Older Veterans Using Problem Solving Therapy

  NCT04763330· VA Office of Research and Development· Updated 16 Jan 2026

  “Funding stopped early”Registry text, quoted unchanged. Source

• Withdrawn

  Effect of App-driven Deep Breathing (NEURODIGITX) on Anxiety Levels and Quality of Life in Caregivers

  NCT05771909· Fondation Hôpital Saint-Joseph· Updated 19 Aug 2025

  “medical device not available”Registry text, quoted unchanged. Source

• Withdrawn

  A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Anxiety

  NCT04211376· ProgenaBiome· Updated 5 Jun 2025

  “Company focus shifted”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder

  NCT07786454· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders

  NCT00397111· National Institute of Mental Health (NIMH)· Source

• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder

  NCT07767903· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Digital Interventions for Relapse Prevention in Adolescence

  NCT07346911· University of Oslo· Source

• Modulating Anxious Coping

  NCT04824105· Medical University of South Carolina· Source

• A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment

  NCT07856420· Intra-Cellular Therapies, Inc.· Source

• High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety

  NCT07233278· Shenyang Medical College· Source

• A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)

  NCT07807865· Intra-Cellular Therapies, Inc.· Source

• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder

  NCT07759128· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

• Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer

  NCT07280416· Centre Hospitalier Emile Roux· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.